|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$0.36 |
$0.37 |
$0.34 |
$0.34 |
1.61M | 03/22/2024 |
$0.36 |
$0.36 |
$0.33 |
$0.35 |
848.80K | 03/25/2024 |
$0.35 |
$0.35 |
$0.32 |
$0.33 |
4.17M | 03/26/2024 |
$0.33 |
$0.36 |
$0.32 |
$0.34 |
1.80M | 03/27/2024 |
$0.35 |
$0.36 |
$0.32 |
$0.33 |
1.55M |
|
Tonix Pharmaceuticals Holding is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. Co. is building capabilities in synthetic biology, precision medicine, protein engineering, medicinal chemistry, molecular biology, pharmacogenomics and clinical-scale manufacturing. Co.'s therapeutics under development include both small molecules and biologics. Co.'s portfolio consists of central nervous system (CNS) rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. | |
|
Tonix Pharmaceuticals Holding (TNXP) has the following price history information. Looking back at TNXP historical stock prices for the last five trading days, on March 21, 2024, TNXP opened at $0.36, traded as high as $0.37 and as low as $0.34, and closed at $0.34. Trading volume was a total of 1.61M shares. On March 22, 2024, TNXP opened at $0.36, traded as high as $0.36 and as low as $0.33, and closed at $0.35. Trading volume was a total of 848.80K shares. On March 25, 2024, TNXP opened at $0.35, traded as high as $0.35 and as low as $0.32, and closed at $0.33. Trading volume was a total of 4.17M shares. On March 26, 2024, TNXP opened at $0.33, traded as high as $0.36 and as low as $0.32, and closed at $0.34. Trading volume was a total of 1.80M shares. On March 27, 2024, TNXP opened at $0.35, traded as high as $0.36 and as low as $0.32, and closed at $0.33. Trading volume was a total of 1.55M shares.
TNXP Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Tonix Pharmaceuticals Holding shares, starting with a $10,000 purchase of TNXP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$333,120.00 |
|
End price/share: |
$0.33 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-74.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.01 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $0.34 | 03/22/2024 | $0.35 | 03/25/2024 | $0.33 | 03/26/2024 | $0.34 | 03/27/2024 | $0.33 |
|
|